SWOT analysis of AstraZeneca analyses the brand/company with its strengths, weaknesses, opportunities & threats. In AstraZeneca SWOT Analysis, the strengths and weaknesses are the internal factors whereas opportunities and threats are the external factors.
SWOT Analysis is a proven management framework which enables a brand like AstraZeneca to benchmark its business & performance as compared to the competitors and industry. AstraZeneca is one of the leading brands in the pharma and healthcare sector. The table below also lists the top AstraZeneca competitors and elaborates AstraZeneca market segmentation, target group, positioning & Unique Selling Proposition (USP).
| AstraZeneca Brand Analysis | |
|---|---|
| Parent Company |
AstraZeneca Biopharmaceuticals |
| Category |
Pharmaceutical |
| Sector | |
| Tagline/ Slogan |
Health connects us all |
| USP |
AstraZeneca is a global, innovation-driven, integrated biopharmaceutical company. |
| AstraZeneca STP | |
| Segment |
Cardiovascular, neuroscience, gastrointestinal, oncology, infection & respiratory diseases |
| Target Group |
Healthcare professionals, doctors, hospitals offering treatments for above mentioned diseases |
| Positioning |
They are responsible for development of prescription medicines for six important areas of healthcare such as cancer, infection. |
| AstraZeneca SWOT Analysis | |
| Strengths |
Below is the Strengths, Weaknesses, Opportunities & Threats (SWOT) Analysis of AstraZeneca. Strengths are: 1. Rapid decision making & streamlined due diligence processing 2. Good commercial and R&D presence in emerging markets 3. Active in over 100 countries employing over 60,000 people 4. High investment in R&D with 11,000+ dedicated R&D team 5. Ten products with global sales above 1 billion dollar |
|
Weakness |
Here are the weaknesses in the AstraZeneca SWOT Analysis: 1. It was affected by drug shortage crisis as in case of Cefotan 2. Product discontinuation affects the performance 3. Legal proceedings related to patents and pricing issues affect image |
| Opportunities |
Following are the Opportunities in AstraZeneca SWOT Analysis: 1. It can leverage its strong presence in emerging markets 2. Increasing importance of biosimiler market 3. Increasing global ageing population |
| Threats |
The threats in the SWOT Analysis of AstraZeneca are as mentioned: 1. Seroquel their blockbuster drug is facing threat of copycat generic drugs 2. Stringent drug development guidelines |
| AstraZeneca Competition | |
| Competitors |
Below are the top 4 AstraZeneca competitors: 1. Amgen 3. Teva Pharmaceuticals 4. GlaxoSmithKline |
The brandguide table above concludes the AstraZeneca SWOT analysis along with its marketing and brand parameters.
Similar analysis has also been done for the competitors of the company belonging to the same category, sector or industry. Browse marketing analysis of more brands and companies similar to AstraZeneca. The BrandGuide section covers SWOT Analysis, USP, STP & Competition of more than 6000 brands from over 20 categories. This SWOT and marketing analysis has been researched & authored by our BrandGuide Research Team members.
Search & Explore : BrandGuide
Write for Us!
Quizzes & Skills!
Quizzes test your expertise in business and Skill tests evaluate your management traits
Related Business Content
Top Companies Lists
All Sections on MBASkool
